Keryx Biopharmaceuticals (KERX) Starts Chronic Kidney Disease Treatment Study – iStockAnalyst
Keryx Biopharmaceuticals (KERX) Starts Chronic Kidney Disease Treatment StudyiStockAnalyst(By Balaseshan) Keryx Biopharmaceuticals (NASDAQ: KERX) said it has initiated a phase 2 study of Zerenex (ferric citrate) for the treatment of patients with stage…
